Clinical Trial Update: Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial [Phase 2]

View source ↗

Summary

A randomized Phase II trial evaluating neoadjuvant chemotherapy with carboplatin and docetaxel in patients with advanced ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Ovarian Neoplasms | Phase 2 | Status: UNKNOWN